NDC 63629-1307

Sucralfate

Sucralfate

Sucralfate is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Sucralfate.

Product ID63629-1307_052b7f38-cafb-44ca-84c3-1ba0241ef0e5
NDC63629-1307
Product TypeHuman Prescription Drug
Proprietary NameSucralfate
Generic NameSucralfate
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date1996-11-11
Marketing CategoryANDA / ANDA
Application NumberANDA070848
Labeler NameBryant Ranch Prepack
Substance NameSUCRALFATE
Active Ingredient Strength1 g/1
Pharm ClassesAluminum Complex [EPC],Organometallic Compounds [CS]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 63629-1307-0

28 TABLET in 1 BOTTLE (63629-1307-0)
Marketing Start Date2022-11-08
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 63629-1307-9 [63629130709]

Sucralfate TABLET
Marketing CategoryANDA
Application NumberANDA070848
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2007-02-07
Inactivation Date2020-01-31

NDC 63629-1307-7 [63629130707]

Sucralfate TABLET
Marketing CategoryANDA
Application NumberANDA070848
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-04-28
Inactivation Date2020-01-31

NDC 63629-1307-2 [63629130702]

Sucralfate TABLET
Marketing CategoryANDA
Application NumberANDA070848
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-04-28
Inactivation Date2020-01-31

NDC 63629-1307-4 [63629130704]

Sucralfate TABLET
Marketing CategoryANDA
Application NumberANDA070848
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-04-28
Inactivation Date2020-01-31

NDC 63629-1307-8 [63629130708]

Sucralfate TABLET
Marketing CategoryANDA
Application NumberANDA070848
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-04-28
Inactivation Date2020-01-31

NDC 63629-1307-3 [63629130703]

Sucralfate TABLET
Marketing CategoryANDA
Application NumberANDA070848
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-04-28
Inactivation Date2020-01-31

NDC 63629-1307-5 [63629130705]

Sucralfate TABLET
Marketing CategoryANDA
Application NumberANDA070848
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-04-28
Inactivation Date2020-01-31

NDC 63629-1307-0 [63629130700]

Sucralfate TABLET
Marketing CategoryANDA
Application NumberANDA070848
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2007-02-07
Inactivation Date2020-01-31

NDC 63629-1307-6 [63629130706]

Sucralfate TABLET
Marketing CategoryANDA
Application NumberANDA070848
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-04-28
Inactivation Date2020-01-31

NDC 63629-1307-1 [63629130701]

Sucralfate TABLET
Marketing CategoryANDA
Application NumberANDA070848
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-04-28
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
SUCRALFATE1 g/1

OpenFDA Data

SPL SET ID:2687d670-8af6-42a2-9081-fee112e80fc0
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 314234

    • Pharmacological Class

    • Aluminum Complex [EPC]
    • Organometallic Compounds [CS]

    NDC Crossover Matching brand name "Sucralfate" or generic name "Sucralfate"

    NDCBrand NameGeneric Name
    0093-2210SucralfateSucralfate
    0121-0747SucralfateSucralfate
    0121-0974SucralfateSucralfate
    0254-1011SucralfateSucralfate
    0378-9205sucralfatesucralfate
    0591-0780SucralfateSucralfate
    0591-3892SucralfateSucralfate
    0615-4517SucralfateSucralfate
    0904-7269SucralfateSucralfate
    17856-0062SucralfateSucralfate Oral
    17856-1011SucralfateSucralfate
    29033-003SucralfateSucralfate
    42291-757SucralfateSucralfate
    42291-781SucralfateSucralfate Oral
    43353-061SucralfateSucralfate
    45865-845SucralfateSucralfate
    50090-0582SucralfateSucralfate
    50090-3019SucralfateSucralfate
    50090-5287SucralfateSucralfate
    50268-732SucralfateSucralfate Oral
    50268-745SucralfateSucralfate Oral
    51079-753SucralfateSucralfate
    51655-031SUCRALFATESUCRALFATE
    53002-4930SucralfateSucralfate
    53808-0593SucralfateSUCRALFATE
    53808-0797SucralfateSUCRALFATE
    55154-4057SucralfateSucralfate
    55154-4379SucralfateSucralfate
    68094-171SucralfateSucralfate
    68788-8946SucralfateSucralfate
    70518-0775SucralfateSucralfate
    71610-244SucralfateSucralfate
    71610-017SucralfateSucralfate
    76519-1025SUCRALFATESUCRALFATE
    55289-292SucralfateSucralfate
    59762-0401SucralfateSucralfate
    60429-297SucralfateSucralfate
    63629-6535SucralfateSucralfate
    63629-1307SucralfateSucralfate
    63739-943SucralfateSucralfate
    66267-596SucralfateSucralfate
    66689-790SucralfateSucralfate
    55154-8133SucralfateSucralfate
    63629-7957SucralfateSucralfate
    55154-5778SucralfateSucralfate
    65162-062SucralfateSucralfate
    68071-1749SucralfateSucralfate
    17856-0170CarafateSucralfate
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.